Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Recovery After Total Knee or Hip Arthroplasty
NCT02685735Phase 4Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2016
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin in postoperative pain, sponsored by Wake Forest University Health Sciences. Primary endpoints: Comparison of Adjusted Trajectory Model for Pain Between Gabapentin and Placebo--Intercept and Comparison of Adjusted Trajectory Model for Pain Between Gabapentin and Placebo--Slope. Started Jun 2016; status: terminated.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02685735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685735.